HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Ørbo, Anne, Arnes, Marit, Lyså, Lena Myreng, Borgfeldt, Christer, Straume, Bjørn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117800/
https://www.ncbi.nlm.nih.gov/pubmed/27711084
http://dx.doi.org/10.1038/bjc.2016.330
_version_ 1782468871536508928
author Ørbo, Anne
Arnes, Marit
Lyså, Lena Myreng
Borgfeldt, Christer
Straume, Bjørn
author_facet Ørbo, Anne
Arnes, Marit
Lyså, Lena Myreng
Borgfeldt, Christer
Straume, Bjørn
author_sort Ørbo, Anne
collection PubMed
description
format Online
Article
Text
id pubmed-5117800
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51178002017-10-25 HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia Ørbo, Anne Arnes, Marit Lyså, Lena Myreng Borgfeldt, Christer Straume, Bjørn Br J Cancer Corrigendum Nature Publishing Group 2016-10-25 2016-10-06 /pmc/articles/PMC5117800/ /pubmed/27711084 http://dx.doi.org/10.1038/bjc.2016.330 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Corrigendum
Ørbo, Anne
Arnes, Marit
Lyså, Lena Myreng
Borgfeldt, Christer
Straume, Bjørn
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title_full HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title_fullStr HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title_full_unstemmed HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title_short HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
title_sort he4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117800/
https://www.ncbi.nlm.nih.gov/pubmed/27711084
http://dx.doi.org/10.1038/bjc.2016.330
work_keys_str_mv AT ørboanne he4isanoveltissuemarkerfortherapyresponseandprogestinresistanceinmediumandlowriskendometrialhyperplasia
AT arnesmarit he4isanoveltissuemarkerfortherapyresponseandprogestinresistanceinmediumandlowriskendometrialhyperplasia
AT lysalenamyreng he4isanoveltissuemarkerfortherapyresponseandprogestinresistanceinmediumandlowriskendometrialhyperplasia
AT borgfeldtchrister he4isanoveltissuemarkerfortherapyresponseandprogestinresistanceinmediumandlowriskendometrialhyperplasia
AT straumebjørn he4isanoveltissuemarkerfortherapyresponseandprogestinresistanceinmediumandlowriskendometrialhyperplasia

Ejemplares similares